Abstract:Openness and sharing of discovery lie at the heart of the scientific method. Yet historically, the data and reports upon which they are based have not been easily accessible and often require onerous efforts to obtain. From this was borne the open data movement, which has advanced research and transformed public health policy-making in countries that have embraced this change. Open health data refers to unrestricted, free-of-charge access to health data [1]. By making health data available to all without any limitations to its reuse, it leverages national transparency, accountability, participation, innovation, and research through a multitude of data sources in large volumes—as well as paving the way for the creation of novel citizen-centric services [1,2]. The ability to access and combine diverse health data enriches analytical capacity and evaluation that can inform national policy development and improve healthcare delivery [3,4]. Open health data is therefore a public resource and should be delivered purposefully and proactively, in line with user needs and its potential contribution to value creation [2]. However, the open data movement comes with the need to balance its benefits with the security and privacy challenges that come with it, such as the risk of re-identification [4]. The issue of selling medical data to commercial organizations such as pharmaceutical companies, insurance companies, and other private companies has also stirred much controversy and raised concerns about ethicality, reproducibility, and generalizability [5]. Undeniably, challenges to the implementation of open health data remain, including the lack of awareness of its potential benefits, unsteady leadership and accountability, and weak legal and ethical oversight. Additionally, addressing the enormous gap in resources and knowledge on tools and techniques is acutely needed to make the technological shift to open and interoperable databases with unified protocols, frameworks, and terminology [3]. Despite the challenges in open health data, numerous countries and institutions have proven its feasibility with the proper legislation and implementation. By incorporating formal requirements in national open data strategies, laws, and regulations, the majority of Organisation for Economic Cooperation and Development (OECD) member countries have successfully adopted and scaled up "open by default" and "government as platform" approaches to data [2]. This has resulted in stronger governance frameworks and an increase in data availability, paving the way for the publication and use of open government data in various sectors geared towards social, government, and business innovation, with potentially important implications for public sector integrity, sustainable development, and gender equality [2]. With the passage of its e-government law, Germany has catapulted its data accessibility in recent years to provide data in machine-readable formats, with metadata descriptions, free of charge, and with unrestricted access for reuse [2]. Upon adoption of its Open Data Charter, Canada also released a number of online databases, such as The Public Health InfoBase and PulseNet Canada, which offer easy-to-use tools for accessing public health data on chronic diseases, mental health conditions, and foodborne molecular surveillance, to name a few [3]. Additionally, the widely utilized, freely-accessible critical care MIMIC databases have provided scientific opportunities for academic and industrial research, quality improvement initiatives, and higher education coursework [6–8]. Conversely, there is a critical need for the United Nations and other global organizations like the World Health Organization (WHO) to develop and espouse open health data as a global strategy as this movement consequently cascades to the regional and national levels.

Open Data in the Era of the GDPR: Lessons from the Human Cell Atlas

Reconciling the biomedical data commons and the GDPR: three lessons from the EUCAN ELSI collaboratory

Data Sharing Under the General Data Protection Regulation: Time to Harmonize Law and Research Ethics?

Who Owns the Data? Open Data for Healthcare

The Commitment of the Human Cell Atlas to Humanity

Human-GDPR Interaction: Practical Experiences of Accessing Personal Data

Enabling responsible public genomics

Balancing the local and the universal in maintaining ethical access to a genomics biobank

Open Data governance at the Canadian Open Neuroscience Platform (CONP): From the Walled Garden to the Arboretum

Bridging the European Data Sharing Divide in Genomic Science

Trends in ethical and legal frameworks for the use of human biobanks

Call to action for global and national actors for open health data

Opening government health data to the public: benefits, challenges, and lessons learned from early innovators

A guide to sharing open healthcare data under the General Data Protection Regulation

Digital phenotyping and sensitive health data: Implications for data governance

Managing expectations, rights, and duties in large-scale genomics initiatives: a European comparison

Raising standards for global data-sharing

Health data sharing and use explored

Abstract 1303: Harness the power of data to improve cancer care - Understanding the complex landscape of health policies and regulations

Responsible data sharing in international health research: a systematic review of principles and norms

Patients' knowledge, preferences, and perspectives about data protection and data control: an exploratory survey